These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 33289681)

  • 1. Human and Veterinary Vaccines for Lyme Disease.
    O'Bier NS; Hatke AL; Camire AC; Marconi RT
    Curr Issues Mol Biol; 2021; 42():191-222. PubMed ID: 33289681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking pathogen transmission at the source: reservoir targeted OspA-based vaccines against Borrelia burgdorferi.
    Gomes-Solecki M
    Front Cell Infect Microbiol; 2014; 4():136. PubMed ID: 25309883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reservoir targeted vaccine against Borrelia burgdorferi: a new strategy to prevent Lyme disease transmission.
    Richer LM; Brisson D; Melo R; Ostfeld RS; Zeidner N; Gomes-Solecki M
    J Infect Dis; 2014 Jun; 209(12):1972-80. PubMed ID: 24523510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyme borreliosis: reviewing potential vaccines, clinical aspects and health economics.
    Šmit R; Postma MJ
    Expert Rev Vaccines; 2015; 14(12):1549-61. PubMed ID: 26414102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease.
    Bhattacharya D; Bensaci M; Luker KE; Luker G; Wisdom S; Telford SR; Hu LT
    Vaccine; 2011 Oct; 29(44):7818-25. PubMed ID: 21816190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease.
    Hassan WS; Giaretta PR; Rech R; Ollivault-Shiflett M; Esteve-Gasent MD
    Vaccine; 2019 Sep; 37(37):5596-5606. PubMed ID: 31387750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live Attenuated Borrelia burgdorferi Targeted Mutants in an Infectious Strain Background Protect Mice from Challenge Infection.
    Hahn BL; Padmore LJ; Ristow LC; Curtis MW; Coburn J
    Clin Vaccine Immunol; 2016 Aug; 23(8):725-31. PubMed ID: 27335385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic infection with Borrelia burgdorferi.
    Steere AC; Sikand VK; Schoen RT; Nowakowski J
    Clin Infect Dis; 2003 Aug; 37(4):528-32. PubMed ID: 12905137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.
    Guarino C; Asbie S; Rohde J; Glaser A; Wagner B
    Vaccine; 2017 Jul; 35(33):4140-4147. PubMed ID: 28668566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against Lyme disease: past, present, and future.
    Embers ME; Narasimhan S
    Front Cell Infect Microbiol; 2013; 3():6. PubMed ID: 23407755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.
    Gomes-Solecki MJ; Wormser GP; Schriefer M; Neuman G; Hannafey L; Glass JD; Dattwyler RJ
    J Clin Microbiol; 2002 Jan; 40(1):193-7. PubMed ID: 11773115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
    Oliver LD; Earnhart CG; Virginia-Rhodes D; Theisen M; Marconi RT
    Vet J; 2016 Dec; 218():27-33. PubMed ID: 27938705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lyme disease vaccine--a public health perspective.
    Shen AK; Mead PS; Beard CB
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s247-52. PubMed ID: 21217171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of the Lyme Disease Spirochetes and its Influence on Immune Responses to Infection and Vaccination.
    Izac JR; Marconi RT
    Vet Clin North Am Small Anim Pract; 2019 Jul; 49(4):671-686. PubMed ID: 30967254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inner Workings: Lyme disease vaccines face familiar challenges, both societal and scientific.
    Shaffer L
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19214-19217. PubMed ID: 31554734
    [No Abstract]   [Full Text] [Related]  

  • 18. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis.
    Klouwens MJ; Trentelman JJ; Ersoz JI; Nieves Marques Porto F; Sima R; Hajdusek O; Thakur M; Pal U; Hovius JW
    Sci Rep; 2021 Feb; 11(1):4775. PubMed ID: 33637813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic diversity of Borrelia burgdorferi sensu stricto in Peromyscus leucopus, the primary reservoir of Lyme disease in a region of endemicity in southern Maryland.
    Anderson JM; Norris DE
    Appl Environ Microbiol; 2006 Aug; 72(8):5331-41. PubMed ID: 16885284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.